(S)-4-(4-cyano-2-methoxyphenyl)-2,8-dimethyl-5-(oxetan-3-yloxy)-1,4-dihydro-1,6-naphthyridine-3-carboxamide

Catalog No. :
ACRJIF867
CAS No. :
2389019-48-9
Molecular Formula :
C22H22N4O4
Molecular Weight :
406.44

IUPAC Name:(S)-4-(4-cyano-2-methoxyphenyl)-2,8-dimethyl-5-(oxetan-3-yloxy)-1,4-dihydro-1,6-naphthyridine-3-carboxamide

(S)-4-(4-cyano-2-methoxyphenyl)-2,8-dimethyl-5-(oxetan-3-yloxy)-1,4-dihydro-1,6-naphthyridine-3-carboxamide structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
No pack options available.

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name(S)-4-(4-cyano-2-methoxyphenyl)-2,8-dimethyl-5-(oxetan-3-yloxy)-1,4-dihydro-1,6-naphthyridine-3-carboxamide
IUPAC Name(S)-4-(4-cyano-2-methoxyphenyl)-2,8-dimethyl-5-(oxetan-3-yloxy)-1,4-dihydro-1,6-naphthyridine-3-carboxamide
Molecular FormulaC22H22N4O4
Molecular Weight406.44
SMILESCOC1=CC(C#N)=CC=C1[C@@H]1C(C(N)=O)=C(C)NC2=C1C(OC1COC1)=NC=C2C
InChI KeyMLWXRFIZLDOCBN-GOSISDBHSA-N
Synonym1,6-Naphthyridine-3-carboxamide, 4-(4-cyano-2-methoxyphenyl)-1,4-dihydro-2,8-dimethyl-5-(3-oxetanyloxy)-, (4S)-;Finerenone Impurity 21;(4S)-4-(4-Cyano-2-methoxyphenyl)-1,4-dihydro-2,8-dimethyl-5-(3-oxetanyloxy)-1,6-naphthyridine-3-carboxamide (Finerenone Impurity)
CAS No.2389019-48-9

Synthetic Route by SureRoute

1. ACRJIF867 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACRJIF867 route product structure diagram
    ACRJIF8672389019-48-9
Inquiry

2. ACRJIF867 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACRJIF867 route product structure diagram
    ACRJIF8672389019-48-9
Inquiry

Comments (0)